HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model.

Abstract
Hepatitis-B vaccine (HBVv) can prevent HBV-infection and associated liver diseases. However, concerns regarding its safety, particularly among patients with autoimmune diseases (i.e. SLE) were raised. Moreover, the aluminum adjuvant in HBVv was related to immune mediated adverse events. Therefore, we examined the effects of immunization with HBVv or alum on SLE-like disease in a murine model. NZBWF1 mice were immunized with HBVv (Engerix), or aluminum hydroxide (alum) or phosphate buffered saline (PBS) at 8 and 12 weeks of age. Mice were followed for weight, autoantibodies titers, blood counts, proteinuria, kidney histology, neurocognitive functions (novel object recognition, staircase, Y-maze and the forced swimming tests) and brain histology. Immunization with HBVv induced acceleration of kidney disease manifested by high anti-dsDNA antibodies (p < 0.01), early onset of proteinuria (p < 0.05), histological damage and deposition of HBs antigen in the kidney. Mice immunized with HBVv and/or alum had decreased cells counts mainly of the red cell lineage (p < 0.001), memory deficits (p < 0.01), and increased activated microglia in different areas of the brain compare with mice immunized with PBS. Anxiety-like behavior was more pronounced among mice immunized with alum. In conclusion, herein we report that immunization with the HBVv aggravated kidney disease in an animal model of SLE. Immunization with either HBVv or alum affected blood counts, neurocognitive functions and brain gliosis. Our data support the concept that different component of vaccines may be linked with immune and autoimmune mediated adverse events.
AuthorsNancy Agmon-Levin, María-Teresa Arango, Shaye Kivity, Aviva Katzav, Boris Gilburd, Miri Blank, Nir Tomer, Alex Volkov, Iris Barshack, Joab Chapman, Yehuda Shoenfeld
JournalJournal of autoimmunity (J Autoimmun) Vol. 54 Pg. 21-32 (Nov 2014) ISSN: 1095-9157 [Electronic] England
PMID25042822 (Publication Type: Journal Article)
CopyrightCopyright © 2014 Elsevier Ltd. All rights reserved.
Chemical References
  • Antibodies, Antinuclear
  • Hepatitis B Vaccines
Topics
  • Animals
  • Antibodies, Antinuclear (immunology)
  • Brain (immunology, pathology, physiopathology)
  • Cognition (drug effects)
  • Disease Models, Animal
  • Female
  • Hepatitis B Vaccines (adverse effects, pharmacology)
  • Lupus Nephritis (immunology, pathology, physiopathology)
  • Mice
  • Proteinuria (immunology, pathology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: